Ongoing Clinical Trials

Abstract OT2-03-04: A trial of induction Talazoparib followed by a combination of Talazoparib and Avelumab in advanced breast cancer: The TALAVE study

Pub Date : 2020-02-15 DOI: 10.1158/1538-7445.sabcs19-ot2-03-04 A. Heeke, M. Pishvaian, Hongkun Wang, A. Cohen, J. Schlom, R. Donahue, C. Jochems, M. Gatti-Mays, P. Pohlmann, A. Tan, C. Isaacs, F. Lynce

Abstract OT3-07-01: Efficacy of magnetic resonance-guided high intensity focused ultrasound for the ablation of breast cancer

Pub Date : 2020-02-15 DOI: 10.1158/1538-7445.sabcs19-ot3-07-01 J. Maar, R. Deckers, L. Bartels, T. Dalen, J. Gorp, P. Diest, A. Witkamp, H. Vaessen, Maria NicoleGerardineJohanna Aleida Braat, C. Moonen

Abstract OT1-04-02: POSITIVE: A study evaluating pregnancy, disease outcome and safety of interrupting endocrine therapy for premenopausal women with endocrine responsive breast cancer who desire pregnancy (IBCSG 48-14/big 8-13)

Pub Date : 2020-02-14 DOI: 10.1158/1538-7445.sabcs19-ot1-04-02 O. Pagani, A. Partridge, F. Peccatori, H. Azim, C. Shimizu, C. Saura, E. Warner, A. Sætersdal, J. Kroep, M. Ruggeri, R. Gelber